CD155 blockade improves survival in experimental sepsis by reversing dendritic cell dysfunction

Yan Meng(Harbin Medical University), Rui Bao(Changhai Hospital), Xiaoming Deng(Second Military Medical University), Zhenzhen Zhao(Lanzhou University), Tao Yang(Gaochun People's Hospital), Wenzhong Zhu(Second Military Medical University)
Biochemical and Biophysical Research Communications
June 11, 2017
10.1016/j.bbrc.2017.06.037
Cited by 24

Related Papers

Serum miR-146a and miR-223 as potential new biomarkers for sepsis
|Biochemical and Biophysical Research Communications|2010|361
PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
|Critical Care|2010|307
Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients
|Critical Care|2011|254
Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis
|Blood|2021|218
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
|Critical Care|2011|215